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Rotational-echo double resonance (REDOR) is a solid-state NMR technique that has the capability of providing intra- and intermolecular
distance and orientational restraints in non-crystallizable, poorly soluble heterogeneous molecular systems such as cell membranes and cell walls.
In this review, we will present two applications of REDOR: the investigation of a magainin-related antimicrobial peptide in lipid bilayers and the
study of a vancomycin-like glycopeptide in the cell walls of Staphylococcus aureus.
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In addition to fluorescence spectroscopy, neutron diffraction,
and a number of other techniques, solid-state NMR has proven
to be a powerful technique to gain insight into the modes of
action of peptide antibiotics [1,2]. The incorporation of site-
specific 13C, 15N, 2H, and 19F labels into the amino acid
sequence provides a way to monitor the secondary structure,
location, and aggregation properties of peptide chains within
lipid bilayers and cell walls, as well as to characterize their
structural and dynamic effects on their surroundings (e.g., lipid
order in a membrane).
After a brief introduction to solid-state NMR, we will
describe two applications of rotational-echo double resonance
(REDOR), a solid-state NMR technique for the measurement of
weak heteronuclear dipolar couplings [3–5], in our investiga-
tion of peptide antibiotics. In one example, the investigation of
K3 (KIAGKIAKIAGKIAKIAGKIA), a synthetic analogue [6]
of the Xenopus peptide PGLa [7], will be presented. This
peptide exhibits higher antimicrobial activity than any of the
native Xenopus peptides (including magainins [8–10]), while
maintaining low hemolytic activity at its antimicrobial concen-
tration and had been under clinical trial for the treatment of
diabetic foot ulcers. In another example, we will summarize the
results of our experiments on [19F]oritavancin (Eli Lilly
compound LY329332), a vancomycin analogue of improved
activity.
2. High-resolution NMR in the solid state
2.1. Lineshape-dominating interactions in solid-state NMR
In addition to the external static (Bo) and alternating (Brf)
magnetic fields, the two most relevant interactions for an
isolated pair of spin-1/2 nuclei (e.g., 13C, 15N, 31P, 19F) in the
solid state are the chemical shift anisotropy (CSA) and the
dipolar coupling. For nuclei with spin quantum number larger
than 1/2 (e.g., 2H), there is an additional interaction, the
quadrupolar coupling. The energy of the spin system – referred
to as the nuclear spin Hamiltonian – can be calculated as the
sum of the individual spin interactions [11–14]. While the
external fields provide the basis for magnetic resonance, the
three other terms contribute to the local fields that influence
the nuclei and that carry important structural information.
All three of these interactions depend upon the orientation of
the molecular segment with respect to the external magnetic
field. For instance, the chemical shift anisotropy originates from
the fact that the electron cloud around the nucleus generates an
additional local magnetic field, which ‘shields’ the nucleus from
the external magnetic field. As the shape of the electron clouddepends upon the bonding network, the shift of the precession
frequency from that of the unshielded nucleus will be a function
of the polar and azimuthal angles that define the orientation of
the molecular segment in the laboratory frame (an xyz
coordinate system whose z-axis is pointing parallel to Bo).
Similarly, for the dipolar and quadrupolar couplings, the energy
of the interaction depends upon the relative orientation of the
molecular segment with respect to Bo. Both of these interactions
will give rise to a splitting of the resonance signal just as J
couplings cause splittings in solution NMR. In addition to the
orientation dependence discussed above, the magnetic energy
that two interacting nuclei acquire in each others field is also
dependent upon the distance between the two spins (1/r3),
making the dipolar interaction highly valuable in structural
studies.
In solution state, fast isotropic tumbling of the molecules
averages out the orientation dependent terms, leaving only the
isotropic chemical shift and scalar coupling in the NMR
spectrum. In molecular systems that exhibit no or only restricted
motion on the time-scale of anisotropic spin-interactions (such
as membrane proteins in lipid bilayers), these spin-interactions
dominate the lineshape. In systems in which all possible
molecular orientations are present with equal probabilities, the
stationary NMR experiment results in an inhomogeneously
broadened powder pattern. Although a tremendous amount of
structural information is encoded in this pattern, for a multispin
system, most of it is completely hidden in the broadened
lineshape.
2.2. Line-narrowing techniques in solid-state NMR
There are three main approaches for obtaining high-
resolution spectra in solid-state NMR. One approach relies
upon orienting the sample, either mechanically [15] or with an
external magnetic field [16,17]. In this case, the uniaxial
orientation provides a mechanism for line narrowing, yet the
structural information inherent in the anisotropic spin interac-
tions is retained.
Another approach originally developed for 1H NMR is
‘multiple pulse line-narrowing’ [18–20] which involves the
rotation of nuclear spins by radiofrequency (RF) pulses in such
a way that over a cycle the average homonuclear dipolar
interaction vanishes. This methodology later on provided the
basis for the development of the so-called separated local field
(SLF) experiments [21,22] in which the anisotropic chemical
shift and heteronuclear dipolar coupling interactions are sorted
into different spectral dimensions. Over the last decade, SLF
experiments, such as PISEMA (polarization inversion spin
exchange at the magic angle) [23] have proven to be highly
powerful techniques in the study of aligned membrane samples.
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solid-state NMR is magic angle spinning (MAS) [24,25]. MAS
increases spectral resolution by mechanically rotating the
sample about an axis aligned at a specific angle (54.7°, the
magic angle) relative to the external magnetic field. During
spinning, the spatial orientation of the nuclei is constantly
changing, making their spin interactions and resonance
frequencies time dependent. With a handful of trigonometric
manipulations, it can be shown that ultra-fast MAS results in an
averaging of the CSA to the isotropic chemical shift. This
means that the NMR signal will be fully recovered after each
rotor period yielding a rotational-echo train. Fourier transfor-
mation of the echo train results in a spectrum consisting of, inFig. 1. (A) REDOR pulse sequence using the XY8 pulse cycling scheme [29] to elim
the abundant protons, a π pulse is applied in the middle of each rotor cycle on the I spi
spaced π pulses per rotor period results in the dephasing of the transverse S magnetiz
cycles of dephasing. The effect of protons is removed by high-power decoupling duri
under the same conditions, without the application of the dephasing π pulses on the I
(......) spin pairs at different distances. The initial slope depends on the gyromagnetic
the slope is determined solely by the internuclear distance.general, a centerband at the isotropic chemical shift frequency
and sidebands separated by the spinning frequency. The
sideband intensities depend upon the strength of the internal
interactions and decrease with increasing spinning speed.
Similarly to the CSA interaction, it can be shown that the
alignment of the rotor axis at the magic angle with respect to Bo
has an averaging effect on the dipolar coupling as well. In
particular, when the spinning speed exceeds the strength of the
dipolar interaction (which in a multispin system is most often
needed to avoid the overlap of spinning sidebands), the latter
will be averaged to zero. This means that fast spinning results not
only in simplification of the spectrum and increased resolution,
but also in the loss of important structural information.inate the effects of offsets and pulse imperfections. After cross-polarization from
n and at the end of each rotor period on the S spin. Application of the two equally
ation. Signal acquisition begins two rotor cycles after the completion of 8N rotor
ng the evolution and acquisition periods. The full echo spectrum (So) is obtained
channel. (B) REDOR dephasing curves for isolated 13C–15N (____) and 13C–19F
ratios of the coupled nuclei and the distance between them. For a given spin pair
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Since the introduction of MAS, numerous NMR techniques
have been designed to reintroduce homo- and heteronuclear
dipolar couplings under MAS conditions [26–28]. Dipolar
interactions can be recoupled by either carefully selecting the
rotational frequency to match a nuclear energy level or by
the application of rotor-synchronized radiofrequency pulse
trains.
For instance, a typical pulse sequence for an I–S rare-spin
pair in a REDOR experiment is shown in Fig. 1A [3,4,29]. In
this case, S is the observed spin and I is the so-called dephasing
spin. The experiment starts with the establishment of transverse
magnetization of spin S by cross-polarization transfer from the
abundant proton reservoir, followed by a dipolar evolution
period that contains two sets of rotor-synchronized interleaved
pulse trains. One set consists of I-spin π pulses in the middle of
each rotor period, and the other set consists of S-spin π pulses at
the end of each rotor period. Two spectra are collected: one with
the pulses on the I channel to produce the dephased spectrum (S)
and another one without the dephasing pulses to produce the full
echo signal (So). The difference between the two spectra
(ΔS=So−S) depends on the I–S dipolar coupling and hence on
the I–S internuclear distance (Fig. 1B).
REDOR measures internuclear distances up to 6–20 Å,
depending on the gyromagnetic ratios and the sensitivities of the
nuclei involved. Two advantages of REDOR are that it does not
depend on the chemical shift tensors of the coupled nuclei and
that it does not require the resolution of the I–S dipolar coupling
in the chemical shift dimension. A complication is that natural-
abundance contributions must be taken into account. In some
cases, comparison with an unlabeled sample is necessary which
can be elaborate and time consuming. To overcome these
difficulties, a pulse sequence called transferred echo double
resonance (TEDOR) [30] was developed in which the dipolar-
coupled spins can be selected from the background of
uncoupled spins. TEDOR can be used alone or in combination
with a REDOR sequence. For example, an S–X dipolar
coupling in a specific I–S–X labeled triplet can be measured
by first selecting the S spin by a coherence transfer from I. The
TEDOR selection is followed by the REDOR part in which the
dipolar coupling between spins S and X is determined.
In addition to REDOR and TEDOR, there are a number of
other techniques to reintroduce the dipolar coupling into MAS
spectra. The list includes R2 [31], DRAMA [32], SEDRA [33],
CEDRA [34], DRAWS [35], CROWN [36], HORROR [37],
BABA [38], C7 [39], RFDR [40], MELODRAMA [41], R3 [42,
43]. These techniques are discussed in detail in several excellent
reviews [26,28,44].
3. Applications of REDOR in the study of antimicrobial
peptides
3.1. Antimicrobial peptides: new candidates for antibiotics
Over the past several decades, the search for new drugs and
target sites has prompted an interest in a group of short, 10–40 residue polypeptides, called antimicrobial peptides
(AMPs). As part of the innate defense system, AMPs provide
protection against a wide variety of microorganisms in both
vertebrates and invertebrates [45–51]. Their killing mecha-
nism is thought to involve ion channel or pore formation and
the dissipation of the electrochemical gradient across the
bacterial cell membrane. In some cases, there are indications
that killing may require a more robust disintegration of the
pathogenic cell membrane [52,53]. At a time of increasing
bacterial resistance, the physical nature of their killing
mechanism makes them one of the most intriguing and
promising candidates for novel antibiotics. Understanding
their mode of action at the molecular level is crucial for AMP-
based drug development. Solid-state NMR offers an oppor-
tunity to investigate the various properties of polypeptide
chains in phospholipid bilayers, which for most antimicrobial
peptides resembles their physiological site of action: the
bacterial cell membrane. With the employment of site-specific
labeling, information on peptide conformation, peptide–
peptide, as well as peptide–lipid interactions can be obtained
at a single residue level.
Currently, there are three main models of peptide-induced
pore formation in lipid bilayers (Fig. 2): (1) In the
conventional barrel-stave model [54,55], peptide chains are
oriented perpendicular to the membrane surface. While their
hydrophobic face interacts with the non-polar lipid acyl
chains, their hydrophilic face forms the interior of a barrel-
stave pore made of several peptides. (2) In the ‘carpet-
mechanism’ [56–58], reorientation of the peptide chains is
hindered by strong electrostatic interactions between the
positively charged peptide sidechains and the often negatively
charged lipid headgroups. Accumulation of peptide chains on
the membrane surface causes tension between the two leaflets
of the bilayer that leads to disintegration/rupture of the
membrane. (3) In the ‘toroid (or wormhole) model’ [10,59],
peptide chains and lipid headgroups together line the wall of
the pore. Although the peptide chains are oriented perpen-
dicular to the membrane surface, due to the reorientation of
the lipid molecules, they remain at the hydrophobic/
hydrophilic interface.
We should note that, recently, significantly different
structural and dynamic characteristics have been obtained for
RTD, the mammalian cyclic θ-defensin [60] by static 2H and
31P NMR experiments of oriented phosphatidylcholine bilayers
[61], which may be an indication of the existence of a fourth
possible mechanism of pore formation.
To distinguish between the various pore models, our ap-
proach has been to introduce specific 13C, 15N, and 19F labels
into K3 so that (i) isotropic chemical shifts reveal its local se-
condary structure at the middle and near both ends of the
peptide chain; (ii) intermolecular heteronuclear dipolar cou-
plings reveal chain aggregation and orientation; (iii) the
proximities of labels in the peptide chains to 31P and 19F
incorporated in the lipids establish the positioning of K3 relative
to the phospholipid headgroups and tails; and (iv) headgroup–
lipid tail contacts provide us with information on the effect of
K3 on lipid chain ordering in the bilayer.
Fig. 2. Cartoons illustrating the permeabilization mechanisms of alpha-helical antimicrobial peptides [51]: (A) barrel-stave, (B) carpet (detergent-like), and (C) toroidal
(wormhole). The hydrophilic and hydrophobic faces of the peptides (shown as cylinders) are colored in blue and gray, respectively. The top-views for the barrel-stave
and the toroidal pore models are shown in boxes.
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The relationship between backbone chemical shifts and
protein secondary structure has long been recognized. In
solution NMR, the chemical shift index (CSI) [62,63] and the
TALOS [64] algorithms were developed in the 1990s and are
widely used methods for secondary structure determination. Ab
initio calculations of shielding surfaces and isotropic chemical
shifts for the amide nitrogen and various carbon atoms in the 20
common amino acids as a function of the backbone torsion
angles are used to confirm and refine the empirical correlations
[65–68].Similarly to the observations in solution NMR, one approach
in obtaining information on peptide secondary structure by
solid-state NMR relies on the fact that alpha-helical methyl and
carbonyl carbon chemical shifts of peptides can differ from
those in beta-sheet conformation by up to 8 ppm [69]. Thus,
carefully positioned, non-perturbing 13C-labels in the sequence
can provide a direct answer. To overcome the difficulty posed
by the large lipid background in the case of membrane-
embedded antimicrobial peptides, dipolar-recoupling techni-
ques can be used under MAS conditions as spectral editing
tools. For instance, in the study of K3, we incorporated 13C and
15N labels at the beginning, middle and end of the peptide chain
Fig. 4. 50.3 MHz 15N→13C{19F} TEDOR-REDOR NMR spectra of a fifty–
fifty mixture of [1-13C]Ala10–[
15N]Gly11–K3–NH2 and [2-
2H, 3-19F]Ala10–
K3–NH2 incorporated into synthetic MLVs of DPPG-DPPC (1:1) at a lipid-to-
peptide molar ratio of 20, after 48 rotor cycles of dipolar evolution with magic-
angle spinning at 5000 Hz [73]. The 48-Tr full-echo spectrum (So) is shown at
the bottom of the figure. The middle spectrum resulted from a 4-Tr
15N→13C
TEDOR coherence transfer followed by 48 additional rotor cycles with high
power proton decoupling. The 48-Tr REDOR ΔS spectrum (where ΔS is the
difference between the 13C echo intensities observed without and with 19F
dephasing pulses) of the TEDOR selected signal is shown at the top of the
figure.







incorporated into MLVs of DPPG and DPPC (1:1) at a lipid-to-peptide molar
ratio of 10, after 8 rotor cycles of dipolar evolution with MAS at 5000 Hz [70].
The full-echo spectrum (So) is shown at the bottom of the figure and the REDOR
difference spectrum (ΔS, the difference between the 13C echo intensities
observed without and with 15N dephasing pulses) at the top.
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individually selected by a specific recoupling scheme, making
it possible to probe the secondary structure at various positions
in the sequence. For example, a completely unambiguous
determination of the carbonyl-carbon resonance frequency of
[1-13C]Ala17 was made using a
13C{15N} REDOR experiment
with a dipolar evolution time of 1.6 ms (8 rotor cycles with
MAS at 5 kHz) (Fig. 3). In this situation, only 13C-s with a
strong, one-bond 13C–15N dipolar coupling appear in the
REDOR difference spectrum, and the only carbonyl 13C in the
labeled sample that fits this description is the carbonyl carbon of
Ala17. This demonstrates the utility of REDOR as a spectral
editing tool. Even if the lipid (upfield shoulder of the peak at
177 ppm) and Ala17 carbonyl peaks were completely unresolv-
able, there would be no interference from the lipid signal in the
difference spectrum.
The resonance frequencies of the 13C methyl carbon of Ala3
and the 13C carbonyl carbon of Ala10 in K3 were determined in
a similar manner, leading to the conclusion that the entire K3
chain was in an alpha-helical conformation in the lipid bilayer.
A similar 13C{15N} REDOR experiment was used to establish
the secondary structure of the C-terminal region of pardaxin, an
antimicrobial peptide from the Red Sea Moses sole fish
Pardachirus marmoratus, in various lipid bilayers [71].
A different method for the determination of peptide
conformation is distance measurement between selectively
labeled residues combined with molecular modeling. This can
be particularly valuable in obtaining structural restraints in less
ordered regions. Also, distance measurements can be used asindependent experiments to confirm the secondary structure
information obtained from chemical shifts. For instance, in a
study of a magainin 2 analogue, the 4.1 Å distance measured
between [1-13C]–Ala15 and [
15N]–Ala19 by REDOR was only
consistent with an alpha-helical conformation and served as an
independent piece of evidence in the structure determination
[72].
3.3. Peptide aggregation
Dipolar recoupling techniques have proven to be highly
valuable in the study of peptide aggregation. For example,
a 13C{19F} REDOR experiment in a selectively labeled sample
can provide intermolecular distance restraints up to 12 Å. This is
well exemplified by the investigation of K3 in phospholipid
model membranes [73] (Fig. 4). The full-echo 13C spectrum (So)
of an equimolar mixture of [1-13C]–Ala10–[
15N]–Gly11–K3
and [3-19F]–Ala10–K3 in multilamellar vesicles of DPPC and
DPPG is shown in the bottom of the figure. Besides the labeled
carbonyl position, this spectrum has contributions from natural
abundance lipid and peptide background. The 13C carbonyl of
Ala10 can be selected by the strong one-bond
13C–15N dipolar
coupling via a short, 4-rotor cycle TEDOR coherence transfer.
The TEDOR sequence is followed by 48 additional rotor
cycles first in the absence (TEDOR-So, middle) then in the
presence of 19F dephasing pulses. The appearance of a sizeable
15N→ 13C{19F} TEDOR-REDOR difference signal (ΔS, top) is
Fig. 6. Cartoon of the dimerized K3 chains obtained from the combination of
distance and angular information [73]. After energy minimization, the [1-13C]
Ala10–[3-
19F]Ala10 and the [1-
13C]Ala17–[3-
19F]Ala14 interchain distances are
4.5 Å and 10.5 Å, respectively. The REDOR determined distances were 4.6 Å
and 10.4 Å. The helices interact at an approximate cross-angle of 20° (inset).




NH2, incorporated into synthetic MLVs of DPPG-DPPC (1:1) at a lipid-to-
peptide molar ratio (L/P) of 20 (closed circles) and 40 (open circles) [73]. Both
samples were lyophilized in a protecting sugar matrix. The solid lines are
simulated dephasing curves that correspond to a bimodal distribution of C–F
distances with the following parameters: i) L/P=20, mean internuclear 13C–19F
separations of 4.6 Å and 9.6 Å with widths of 0.7 Å and 3 Å, respectively; ii)
L/P=40, mean internuclear 13C–19F separations of 4.3 Å and 8.1 Å with
widths of 1.0 Å and 3.2 Å, respectively. At L/P=40, the population with the
smaller mean and narrower distribution width decreases.
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19F]–
Ala10 dipolar coupling and unambiguously proves the proxi-
mity of peptide chains in the membrane.
The measurement of ΔS/So ratios at different dephasing
times (Fig. 5) allows the determination of the separation
between peptide chains, as well as the estimation of the fraction
of peptide molecules, which are near another chain. For K3, at a
lipid-to-peptide molar ratio close to that of the therapeutic
concentration, least-square analysis of the REDOR curve
showed a bimodal distribution of internuclear [1-13C]–Ala10–
[3-19F]–Ala10 distances: a narrow distribution centered at 4.6 Å
and a broad distribution centered at 9.6 Å. (The existence of two
distinct populations of 13C–19F distances is also apparent from
a visual inspection of the REDOR curve, i.e., the ‘bump’ at
short dephasing times.) The narrow distribution at short
interchain distances suggested specific interactions between
K3 chains (dimerization has later on been confirmed by
additional experiments), whereas the broad distribution at
longer distances reflected less specific interactions between
the peptide chains, possibly a loose aggregate of peptide
monomers and dimers in a membrane pore. The population of
closely-packed K3 dimers has increased by almost three-fold
between L/P=40 and L/P=20. The concentration dependent
dimerization of K3 chains was consistent with the sigmoidal
nature of binding isotherms of similar, magainin-like AMPs to
negatively charged lipid vesicles [9,74,75].
Once aggregation is established, distance measurements can
provide information on the relative orientation of peptide chains
within the aggregate. For instance, changing the position of
the 13C and 19F labels in K3, REDOR revealed a head-to-head
arrangement of helices within the dimer [73]. Also, as spinningsidebands in MAS experiments (e.g., the small peaks around 75
and 275 ppm in the TEDOR-So spectrum in the middle of Fig.
4) are composed of their own CSA-weighted distributions of
CSA-tensor orientations, differences in sideband dephasing
rates are indications of a preferred relative orientation between
the CSA and dipolar tensors. This can be exploited for obtaining
orientational restraints in REDOR experiments [76], which in
combination with the interchain distance information and
molecular modeling can lead to the determination of the relative
orientation of two interacting helices in membrane bilayers. For
K3, we obtained a dimer structure in which the two helices
intersect at a cross-angle of ∼20° [73] (Fig. 6). Similar solid-
state NMR experiments have been used with great success to
determine the directionality of amyloid-forming Aβ peptides
[77] and to obtain absolute structural constraints in fibrils [78].
We note that dipolar recoupling experiments can also be used
to gain insight into the size and shape of aggregates. For
instance, if the peptide chains form trimers or larger aggregates,
the distance measurement in a 13C{19F} REDOR experiment is
expected to deviate in a predictable way from that observed for
isolated spin pairs [79]. This can be exploited in titration
experiments where the ratio of the 13C, 15N-labeled peptide
to 19F-labeled peptide is varied. For example, if oligomerization
involves the formation of a peptide hexamer, at low isotopic
concentrations of the 13C, 15N-labeled peptide, each 15N-
selected 13C label in the middle of a peptide chain will be
surrounded by five 19F-labeled peptides. In combination with
molecular modeling, the positions of all five 19F labels might be
inferred from REDOR experiments in which the dipolar
evolution time is varied.
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bilayers
The phosphorous atom in phospholipid headgroups (a
spin-1/2 isotope of 100% abundance) is a natural spin label
that can be exploited in obtaining distance restraints. By
incorporating 13C or 15N labels at various locations in the
peptide sequence, 13C{31P} and 15N{31P} REDOR experi-
ments can be used to determine their proximity to the lipid
headgroups. For instance, the 13C{31P} REDOR full-echo








Gly18-labeled K3 incorporated into multilamellar vesicles of
DPPC/DPPG (1:1) at a lipid-to-peptide molar ratio of 20 is
shown in Fig. 7 after 19.2 ms of dipolar evolution time [70]. The
sizeable dephasing at 177.2 ppm arises from 13C carbonyl labels
at Ala10 and Ala17 (see above on Secondary structure) and
indicates the proximity of the peptide chain to the phosphorous
headgroups. (The upfield peak at 173.2 ppm in both spectra is
from natural abundance 13C lipid carbonyls whose dephasing
arises mainly from short intramolecular 13C–31P contacts in the
phospholipids with a small intermolecular contribution between
neighboring lipid headgroups.) We note that the 13C label at
Ala17 could have also been selected via the [1-
13C]Ala17–[
15N]
Gly18 one-bond heteronuclear dipolar coupling preceding
the 31P dephasing if desired. In addition to the peaks in the
carbonyl region, the peak in theΔS spectrum at 16.1 ppm can be








15N]Gly18–K3–NH2, incorporated into synthetic MLVs of DPPG-
DPPC (1:1) at a lipid-to-peptide molar ratio of 20 after 96 rotor cycles of dipolar
evolution with magic-angle spinning at 5000 Hz [70]. The Cα of Gly has a short
T2 relaxation and therefore it is not observed in the spectrum after 96 rotor
cycles. An expansion of the 175 ppm region of the difference spectrum is shown
in the inset.between the N-terminal region of the peptide and the lipid
headgroups.
By monitoring the 13C{31P} dephasing for the carbonyl car-
bon at Ala10 as a function of dipolar evolution time, we obtained
an apparent average C–P distance of 5 Å for K3 at peptide
concentrations where pore formation was observed. We should
emphasize that since there are multiple phosphorous dephasers
whose contributions in this situation are difficult to deconvo-
lute, this is only a qualitative determination of the proximity of
Ala10 to the lipid headgroups (±1 Å). However, the extent of
peptide–headgroup contact as a function of peptide concentra-
tion became a valuable piece of evidence in the exclusion of the
possibility of a barrel-stave pore model [70,73].
To obtain more information on the orientation of K3 in
membrane systems, we also carried out static NMR experiments
on oriented lipid bilayers. Static NMR experiments are
extensively used in the study of AMPs [80–83] and membrane
proteins in general and have recently been reviewed in detail
[84]. For K3, they showed a reorientation of peptide chains
between L/P=200 and L/P=20 [73] and provided a crucial
piece of evidence in the establishment of the pore model.
3.5. The effect of AMPs on lipid order in the bilayer
The analysis of static 31P and 2H spectra of phospholipid
bilayers containing various amounts of an antimicrobial peptide
can reveal important details on how that particular AMP
influences the structure and dynamics of lipid bilayers [81,85],
including the effect on membrane curvature and phospholipid
morphology [82].
As an alternative approach, information on lipid order in the
presence and absence of antimicrobial peptides can also be
obtained by the characterization of the headgroup–lipid tail
contact in the bilayer. This can be done, for instance, by the
incorporation of an 19F label at low, non-perturbing concentra-
tions into the tail of lipid acyl chains and the employment of
a 31P{19F} REDOR experiment. This is shown in Fig. 8A for
MLVs of DPPG/DPPC (2.5 mol% F-lipid included) with and
without the incorporation of the synthetic magainin-analogue,
K3, as a function of dipolar evolution time [70]. The presence of
the peptide results in a larger fraction of lipid headgroups that
are in proximity to the lipid tails (higher plateau), and a shorter
average P–F distance (larger slope of the ΔS/So curve). In
addition, the distribution of P–F distances increases dramati-
cally (Fig. 8B), indicating an increased disorder among the lipid
molecules when K3 is present.
3.6. Pore model
During the last decade or so, solid-state NMR provided
direct structural evidence for several AMPs that enabled the
investigators to distinguish between various pore models. The
studies usually employ a combination of several different types
of NMR experiments (often both static and MAS experiments),
each directed at specific aspects of the mode of action of AMPs.
In our investigation of K3, 13C{31P} REDOR experiments
have proven the proximity of the middle of the peptide chains
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nism. At the same time, static NMR experiments on
specifically 19F-labeled K3 in oriented lipid bilayers have
shown a change in orientation of the K3 helix relative to the
bilayer normal with increasing peptide concentration. This,
and the absence of sharp, isotropic peaks from the static 31P
spectra excluded the possibility of micellization and therefore
the carpet mechanism. 13C{19F} REDOR experiments on the
mixture of specifically 13C or 19F labeled peptides have
proven the dimerization of K3 chains within the lipid bilayer
as well as the existence of a less specific, larger association ofFig. 9. Cartoons of the K3 pore model: cross section (top) and top view (bottom)
[73]. K3 monomers and dimers are shown in yellow and red, respectively.
Lysine side chains are indicated in blue. Peptide chains and lipid headgroups
together line the wall of the torus-like pore. A few of kinked lipid chains have
19F-labeled tails (green) near the phospholipid headgroups.
Fig. 8. 81-MHz 31P{19F} REDOR dephasing (ΔS/So) of DPPG/F-DPPG/DPPC/
F-DPPC (48.75:1.25:48.75:1.25) MLVs in the presence (closed circles) and in







15N]Gly18–K3–NH2 at a lipid-to-peptide
molar ratio of 20 [70]. Both samples were lyophilized in a protecting sugar
matrix. (A) The solid lines drawn through the experimental points are simulated
dephasing curves assuming a distribution of isolated 31P–19F spin pairs with a
mean internuclear separation of 7.6 Å and a distribution width of 5.4 Å (solid
circles), or a mean internuclear separation of 9.9 Å with a distribution width of
1.6 Å (open circles). (B) Distribution of 31P–19F distances in the presence and
in the absence of K3 in the bilayer. F-DPPG=1-palmitoyl-2-[16-fluoropalmi-
toyl]-phosphatidylglycerol; F-DPPC=1-palmitoyl-2-[16-fluoropalmitoyl]-
phosphatidylcholine.monomers and dimers interspersed with lipid headgroups
[73]. All of these results were consistent with the formation of
torus-type pores (Fig. 9) most likely as transient holes in the
bilayer before the collapse of the membrane [86].
4. Applications of REDOR in the study of glycopeptide
antibiotics
4.1. Vancomycin resistance
Vancomycin and other closely related glycopeptides inhibit
the peptidoglycan biosynthesis of the bacterial cell wall of
Gram-positive bacteria [87] (Fig. 10). Cell-wall and septal
thinning result from vancomycin treatment [88] because the
balance between new cell-wall synthesis at the cell-membrane
surface and enzymatic degradation of outer layers (which
normally functions to accommodate cell growth and division) is
dramatically perturbed. The antibiotics do not penetrate into the
cytoplasm of the cell but form complexes with the D-Ala–D-
Ala carboxyl termini of peptidoglycan precursors outside the
cell membrane [89,90], including lipid II, which is the
peptidoglycan repeat unit complexed to a C55-lipid transporter.
In principle, binding of vancomycin to lipid II could interfere
with the activity of transglycosylase and transpeptidase [91–
94]. Both are essential for the synthesis of new cell wall. The
former extends the glycan chain and the latter cross-links the
peptide stems with the subsequent elimination of the terminal
D-Ala. Solid-state NMR measurements have been used to
measure the production of cross-links and bridge-links in the
cell walls of actively dividing S. aureus. These experiments
showed that transglycosylation is inhibited by vancomycin
before any effect on transpeptidation is observed [94].
Fig. 10. (Top) Schematic representation of an idealized version of the cell-wall
peptidoglycan of S. aureus (after Stryer). A four-unit peptide stem (triangles)
having the sequence, L-Ala–D-iso-Gln–L-Lys–D-Ala, is attached to every
second sugar of the glycan backbone (open circles). Cross-linking between
glycans occurs through pentaglycyl bridges (dark circles) connecting the
carbonyl carbon of D-Ala of the fourth position of one stem with the ε nitrogen
of L-Lys of the third position of another. (Bottom) Chemical structure of the
peptidoglycan of S. aureus. The five-residue stem on the right has no cross-link
to its D-Ala–D-Ala terminus.
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last resort because of its toxicity and the relatively high costs
associated with its administration. When used, however, it was
consistently effective [93,95,96]. This began to change with the
emergence of vancomycin-resistant enterococci and staphylo-
cocci. Vancomycin-resistant enterococci (VRE) appeared
around 1988 [97]. The first clinical isolate of S. aureus with
reduced susceptibility to vancomycin (minimum inhibitory
concentration, MIC, equal to 8 μg/mL) was identified in Japan
in 1996 [98]. Full resistance corresponds to an MIC of at least
32 μg/mL. In 2002, vancomycin-resistant S. aureus (VRSA)
with an MIC >128 μg/mL was recovered from a patient in
Michigan who was being treated with multiple courses of
antibiotics [99]. Vancomycin-resistant E. faecalis was also
recovered from the patient. The VRSA isolate contained the
vanAvancomycin-resistance gene clusters from enterococci that
code for the production of D-Ala–D-Lac stem termini and result
in reduced vancomycin binding affinity. This probably occurred
through conjugative transfer from the VRE isolate [100]. In2002 and 2004, two other VRSA clinical isolates of the VanA
type were documented in Pennsylvania and New York [101].
4.2. Potent vancomycin-like glycopeptides
Fluorophenylbenzyl-vancomycin (FPBV) is a vancomycin
derivative exhibiting improved activity against VRE that have
D-Ala–D-Lac stem termini. FPBV is an analog of [19F]
oritavancin (Eli Lilly compound LY329332). Both have a
hydrophobic disaccharide substituent and both show 100-fold
increased activity relative to their parent compounds (Fig. 11,
vertical arrows) on standard tests against VRE [96,98,99,
102,103]. Both chloroeremomycin and [19F]oritavancin have 4-
epi-vancosamine backbone substituents and both have 10-fold
greater antimicrobial activity against VRE, relative to their non-
substituted analogues, vancomycin and FPBV (Fig. 11,
horizontal arrows). Thus, disaccharide substitution and the
presence or absence of 4-epi-vancosamine appear to be
important factors for the enhanced antimicrobial activity of
these vancomycin-like glycopeptides. Neither factor appears to
be directly associated with the D-Ala–D-Ala binding site. An
understanding of where the sugars and sugar substituents are
located relative to the stem termini should help in establishing
modes of action for these drugs.
4.3. [19F]oritavancin proximity to the pentaglycyl bridge and
attached stems
We have used REDOR techniques to measure several dis-
tances from [19F]oritavancin, Eli Lilly compound LY329332
(Fig. 11), and 13C, 15N, and 2H labels incorporated in the cell
walls of S. aureus [104,105]. The drug was complexed to both
isolated cell walls and the cell walls of intact late log-phase
whole cells. Results from the REDOR experiments demon-
strated that when complexed with mature cells, [19F]oritavancin
does not form dimers. Based on 13C{19F} REDOR experiments
on cell-wall complexes of vancomycin-susceptible S. aureus
(Figs. 12 and 13), the 19F of [19F]oritavancin is near a pentaglycyl
bridge connecting two stems [104]. For low occupancy, all
occupied binding sites are stems ending in D-Ala–D-Ala [104].
The bridges are far enough apart that it is unlikely for two bridges
to be near any single vancomycin (cf, below). Fig. 14 shows the
allowed positions of the 19F relative to the five carbonyl carbons
of a compact bridge consistentwith theREDORdephasing [104].
These positions were used to calculate the dephasing shown in
Fig. 13 (solid line). The fluorine can be near one end of the bridge
or the other. The nearest glycyl carbonyl carbon is 5 Å from
the 19F and the farthest is 11 Å. The calculated dephasing plateau
is 6%. The absence of an 15N{19F} REDOR difference for the
amide nitrogen connecting the bridge to the stem [104] rules
out placement of the fluorine at that end of the bridge (the
bridge-link end). The fluorine must therefore be near the cross-
link site [104].
From other REDOR experiments, we determined that the
fluorine of [19F]oritavancin is 7.4 Å from the carbonyl-
carbon 13C of the D-Ala–Gly-1 cross-link that connects the
two stems, and approximately 8 Å from the carbonyl carbon of
Fig. 12. 13C{19F} REDOR NMR spectra for a complex of [19F]oritavancin (Eli Lilly compound LY329332) with cell walls of S. aureus grown on media containing
[1-13C]glycine [103]. REDOR differences (ΔS) are shown at the top of the figure and the full echoes (So) at the bottom. ΔS=So−S, where S and So are the signal
intensities with and without 19F dephasing pulses, respectively. Expanded frequency-scale plots of the carbonyl-carbon regions of the REDOR spectra after 8 rotor
cycles of dipolar evolution (only the signal of the labeled carbonyl-carbon nearest to 19F is dephased) are shown to the right of the figure. The dissimilarity of the
REDOR difference and full-echo spectra (dotted lines) indicates an orientational preference for the 13C–19F internuclear vector relative to the 13C carbonyl-carbon
chemical shift tensor.
Fig. 11. Structures of vancomycin, chloroeremomycin, FPBV (upper left) and [19F]oritavancin. The arrows show the relative enhancements of glycopeptide
antimicrobial activities against vancomycin-resistant enterococci (after S. J. Kim).
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Fig. 13. 13C{19F} REDOR dephasing (ΔS/So) as a function of the dipolar
evolution time, t, for a complex of [19F]oritavancin with cell walls (circles) of S.
aureus grown on media containing [1-13C]glycine [104]. The binding-site
occupancy for 2 μmol of the antibiotic complexed to the cell walls was 16%. The
solid line shows the calculated dephasing assuming the 13C–19F distances of the
model shown in Fig. 15. The breaks in the calculated dephasing arise from the
presence of five significantly different 13C–19F dipolar couplings.
1325O. Toke et al. / Biochimica et Biophysica Acta 1758 (2006) 1314–1329L-Ala of the neighboring stem, with the α carbon closer than the
carbonyl carbon and the methyl carbon farther [105].
4.4. Model of the [19F]oritavancin binding site
A cartoon model of the binding site consistent with the
REDOR results, binding-assay results, and cell-wall composi-Fig. 14. Possible positions for the 19F of [19F]oritavancin [104] (small dots)
relative to the pentaglycyl helix (carbonyl carbons in black, Cα in gray, nitrogens
in blue, and oxygens in red) consistent with the REDOR dephasing of Figs. 12
and 13. The colors of the 19F positions indicate the RMSD between calculated
and experimental dephasing. The best match shown (red) has a 13% error and
the worst match (blue) a 15% error. Most likely placements of 19F relative to the
end carbonyl carbons determined by analysis of the spinning sideband
intensities of Fig. 12 (right) are shown in black. The bridge-link site is near
the top cluster and the cross-link site near the bottom cluster. The absence of
an 15N{19F} REDOR difference for the amide nitrogen connecting the bridge to
the stem (see Fig. 15, left) rules out placement of the 19F near the bridge-link.tional analysis is shown in Fig. 15. The model assumes that the
aglycon cleft binds to a stem terminating in D-Ala–D-Ala in a
locally ordered peptidoglycan matrix. This sort of termination is
indicated by a ball at the bottom of the stem. The cross-link is
attached offset from the idealized stem cylinder (for example,
see the cross-link at center, left). The peptidoglycan of S. aureus
has about ten layers of glycans, only two of which are shown in
Fig. 15. In addition, the glycan chains in both layers are shown
for clarity as strictly parallel, which need not be the case; chains
in adjacent layers may be oblique or rotated about their long
axes relative to one another. In the model, the fluorine of the
biphenyl moiety is not near the L-Ala of the complexed stem,
but rather the L-Ala of a nearest-neighbor stem on an adjacent
glycan strand. This nearest-neighbor stem is shown with a
bridge (85% of all stems have a bridge), and this arrangement is
the source of 19F coupling to the carbonyl carbons of Gly as
well as D-Ala. The complex is presumably stabilized by
interactions of the sugars of [19F]oritavancin with peptidogly-
can sugars. One of these possible interactions is shown in the
center foreground; the other is obscured by the cross-link of the
complexed stem in the foreground [104]. This stabilization may
help to explain the potency of [19F]oritavancin against VRE
with D-Ala–D-Lac stem termini. A space-filling rendering of
the aglycon binding site, the bound stem, the neighboring stem,
and the cross-linking bridge connecting the two is shown in
Fig. 16.
4.5. Complexes at the membrane surface
We enhanced the fraction of observed complexes that are at
the membrane surface by adding glycopeptide and labels forFig. 15. Molecular model of the binding of [19F]oritavancin in mature
peptidoglycan of S. aureus [104]. The glycan strands are shown as gray
cylinders, the peptide stems as blue cylinders, and the pentaglycyl bridges as
light blue cylinders. The helical pitch of the glycan chain places adjacent stems
on the same chain at right angles to one another. Stems ending in D-Ala–D-Ala
have a ball at the end. The vancomycin cleft is shown attached to a stem (dark
blue) ending in D-Ala–D-Ala. The sugar sidechains of [19F]oritavancin are
shown in white and the 19F label in green. The 19F is 8 Å from the carbonyl
carbon of the L-Ala at the base of the peptide stem in the center foreground,
7.4 Å from the carbonyl carbon of D-Ala at the tip of this stem, and 5 Å from the
carbonyl carbon of Gly5 of the pentaglycyl bridge cross-linked to this stem.
Other experimentally established distances are in black.
Fig. 16. Space-filling model of [19F]oritavancin with sugars shown in light blue,
and the aglycon and biphenyl in gray. The D-Ala–D-Ala terminus of a stem
bound to the oritavancin is shown in blue-green, and the cross-linking bridge to
a neighboring stem is shown in red. Both stems are blue. The distance from the
fluorine (green) to the D-Ala carbonyl carbon of the cross-link site is 7.4 Å (solid
line), and to the three carbons of L-Ala of the neighboring stem, about 8 Å (solid
lines). The location of the L-Lys sidechain of the neighboring stem is not
defined.
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whole cells in less than one doubling time for solids NMR
analysis. This is the same protocol used to characterize
biosynthesis [94], only now the goal was to characterize
bound structures using a variety of labeling schemes. For whole
cells of vancomycin-susceptible S. aureus grown in the pre-
sence of [1-13C]glycine and L-[ε-15N]lysine, contact between
an [ε-15N]lysyl amide bridge-link and [19F]oritavancin was
observed for exponentially growing cells [106] but not for
mature cells [104,106]. Although some of the [19F]oritavancin
was bound to partially cross-linked, mature peptidoglycan as
before, with 19F proximate to the cross-link site but not the
bridge-link site (Fig. 14), a sizeable fraction of the [19F]
oritavancin must be bound to D-Ala–D-Ala termini of stems at
or near the membrane surface. The observed new 15N–19F
contact is therefore to the stems of growing new strands that are
neighboring bound stems. The proximity of the fluorobiphenyl
apparently interferes with the formation of the cross-link
between a bound stem and its neighboring stem (Fig. 16), and
forces a relocation of the bridge and bridge-link site of the
neighboring stem so that 15N{19F} dephasing is now observed
[106]. This result suggests an interference with transpeptidation.
At the same time, the observed increase in peptidoglycan
precursors and decrease in the number of stems with bridges
[106] suggests an interference with transglycosylation [94].
Thus, the mode of action of oritavancin acting on vancomycin-
susceptible S. aureus is mixed [106].
5. Conclusions
The constant challenge to combat human infectious diseases
requires knowledge of the structural interactions between
pathogen and host. Atomic-level details to help define the
modes of action of antibiotics are vital for speeding up thedifficult task of discovering new antibiotics and overcoming the
too-rapid emergence of antibiotic resistance.
We have shown the applications of REDOR, a solid-state
NMR technique under magic angle spinning (high resolution)
conditions, for two highly potent peptide antibiotics. For K3, a
synthetic analogue of a magainin-like antimicrobial peptide,
REDOR, in conjunction with static NMR experiments on
oriented samples, revealed a torus-type pore formation in the
bilayers of DPPC-DPPG, in which K3 monomers, dimers and
phospholipid headgroups together line the wall of the pore.
For oritavancin, a vancomycin-analogue, intermolecular dis-
tance and orientation restraints from REDOR suggested an
interference with both transglycosylation and transpeptidation
in the cell walls of S. aureus. The mixed mode of action of
oritavancin might be responsible for its increased activity
against VRE.
The REDOR strategy is generally not one of total
structure determination, but rather one of accessing site-
specific atomic-level information to yield parameters charac-
terizing structure, dynamics, and metabolism in large,
heterogeneous systems. REDOR therefore complements
other MAS [2,107–113] and static NMR experiments [1,84]
in providing useful tools for structural biologists in answering
specific questions regarding the structure and function of
membrane proteins and poorly soluble biomolecular com-
plexes generally.References
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